Πηγαίνετε σε ένα σημείο του ευρετηρίου:
Αποτελέσματα 1 έως 4 από 4
ΤύποςΗμερομηνίαΤίτλοςΔημιουργόςΠλήρες κείμενο
Text
2003Individual DNA damage and repair following exposure to melphaian are inversely associated with clinical outcome in patients with multiple myeloma treated with high dose melphalan and autologous blood stem cell transplantationDimopoulos, M. A.; Sfikakis, P. P.; Anagnostopoulos, A.; Hamilos, G.; Papadimitriou, C.; Souliotis, Vassilis L.
Metadata only
Text
2005Measurement of individual p53-specific damage formation and repair following in vitro exposure of peripheral mononuclear cells to melphalan may predict clinical outcome in patients with multiple myeloma (MM) subsequently treated with high dose melphalan (HDM) and autologous blood stem cell transplantation (ASCT)Dimopoulos, M. A.; Souliotis, Vassilis L.; Anagnostopoulos, A.; Pouli, A.; Baltadakis, I.; Terpos, E.; Sfikakis, P. P.
Metadata only
Text
2005Extent of damage and repair in the p53 tumor-suppressor gene after treatment of myeloma patients with high-dose melphalan and autologous blood stem-cell transplantation is individualized and may predict clinical outcomeDimopoulos, M. A.; Souliotis, Vassilis L.; Anagnostopoulos, A.; Papadimitriou, C.; Sfikakis, P. P.
Metadata only
Text
2006Melphalan-induced DNA damage in vitro as predictor for clinical outcome in multiple myelomaDimopoulos, M. A.; Souliotis, Vassilis L.; Anagnostopoulos, A.; Bamia, C.; Pouli, A.; Baltadakis, I.; Terpos, E.; Kyrtopoulos, Soterios A.; Sfikakis, P. P.
Restricted access